Poly Peptide
CRO & CDMO Services · APIs & Drug Manufacturing
10open roles
Btruth index, 75 of 100
1000+people
22stories in the press
Overview
PolyPeptide Labs is a world leader in the manufacture of polypeptide, custom peptide Synthesis, peptide synthesis and generic peptide : generic GMP peptide and non-GMP peptide. PolyPeptide provides global support for a quality CDMO solution.
How Poly Peptide hires
Truth index
B 75/100
Ghost roles
0%
Stale roles
100%
Reposted roles
0%
Poly Peptide scores B on the Alion truth index (A is best, E worst), measured over 4 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
Jobs
In office · Full-Time · Strasbourg
HPLC
Chromatography
GMP
Apply
In office · Contractor · Strasbourg
Agile
Life Sciences
GMP
Apply
≈ $42k – $71k per year (Estimated) · In office · Full-Time · Strasbourg
Apply
≈ $26k – $41k per year (Estimated) · In office · Full-Time · Strasbourg
GMP
Apply
≈ $26k – $41k per year (Estimated) · In office · Full-Time · Strasbourg
GMP
Apply
≈ $26k – $41k per year (Estimated) · In office · Full-Time · Strasbourg
GMP
Apply
≈ $42k – $72k per year (Estimated) · In office · Full-Time · 8+ years exp · Strasbourg
GMP
MedTech
CAPA
Apply
≈ $30k – $46k per year (Estimated) · In office · Full-Time · Strasbourg
GMP
MedTech
CAPA
Apply
≈ $26k – $42k per year (Estimated) · In office · Full-Time · Strasbourg
HPLC
Chromatography
GMP
Apply
≈ $26k – $41k per year (Estimated) · In office · Full-Time · Strasbourg
GMP
Apply
Growth
Hiring Momentum
32/100
Slowing
Open positions
10
1 opened / 1 closed in 30 days
Median time-to-fill
52 days
faster than 26% of the market
ATS activity
Every ~7 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Field & Service
63% ▼
Management
25% ▲
Customer Success
13% ▼
Activity Timeline
Added CAPA to stack
Oct 2026
Tech stack
Technologies named in job postings at Poly Peptide over the last 12 months, by layer, with the share of postings for each.
Technologies in use
4
Postings analysed
7
Stack modernity
53/100
Practices & domains
GMP
CAPA
Chromatography
HPLC
Sign in to see how your skills match this stack
Sign In
News
Samsung Peptide AG publishes offer prospectus for public tender offer for PolyPeptide Group AG
Baar, 31 August 2026 - PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that Samsung Peptide AG, a direct subsidiary of Samsung Biologics Co., Ltd., a leading global CDMO, has
Read more
Report
PolyPeptide delivers +42% growth in H1 2026 and improved EBITDA margin; 2026 full-year guidance updated, now expecting 25-30% revenue growth and high-teens EBITDA margin
Baar, 13 August 2026 - PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced its H1 2026 results, updated its full-year 2026 guidance and confirmed its mid-term outlook: … Download
Read more
Report
Samsung Biologics announces tender offer to acquire PolyPeptide Group AG for CHF 44.31 per share
Baar, 20 July 2026 - PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced Samsung Biologics' tender offer to acquire PolyPeptide Group AG as well as the successful closing of the
Read more
Report
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
Samsung Biologics (KRX: 207940.KS) today announced the launch of an all-cash public tender offer to acquire 100% of the fully diluted share capital of PolyPeptide Group AG ("PolyPeptide") (ISIN CH1110760852, ticker symbol: PPGN), a leading global contract
Read more
Report
PolyPeptide Group AG takes note of market rumors and speculation
Baar, 14 April 2026 - PolyPeptide Group AG (SIX: PPGN) ("PolyPeptide" or the "Company"), a specialized global CDMO for peptide-based active pharmaceutical ingredients, takes note of recent market speculation and media reports according to which PolyPeptid
Read more
Report
PolyPeptide announces results of the annual General Meeting 2026
Baar, 8 April 2026 - PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that the shareholders approved all proposals put forward by the Board of Directors at the Company's fifth
Read more
Report
PolyPeptide strengthens financing structure through expansion of existing credit facility
Baar, 19 March 2026 - PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the strengthening of its financing structure through the expansion of its existing credit facility. Poly
Read more
Report
PolyPeptide publishes invitation to the annual General Meeting 2026
Baar, 17 March 2026 - PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, published today the invitation to the fifth annual General Meeting, which will take place on 8 April 2026 at the Choller
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Strasbourg
Strasbourg
France
Plant / site
10 open roles 8 posted in 90 days 10% engineering 1000-5000 est. staff
hires for Field & Service, Management, DevOps
7 Rue de Boulogne